Anti-NEK7 antibody [EPR4900]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(2 Reviews)
|
(85 Publications)
Anti-NEK7 antibody [EPR4900] (ab133514) is a rabbit monoclonal antibody detecting NEK7 in Western Blot, IP. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
View Alternative Names
Serine/threonine-protein kinase Nek7, Never in mitosis A-related kinase 7, NimA-related protein kinase 7, NEK7
- IP
Lab
Immunoprecipitation - Anti-NEK7 antibody [EPR4900] (AB133514)
ab133514 immunoprecipitating NEK7. 10μg of cell lysate was incubated with primary antibody at a dilution of 1/20 and VeriBlot for IP Detection Reagent (HRP) (ab131366) at a dilution of 1/1000.
Lane 1 : NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate 10ug
Lane 2 : NIH/3T3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab133514 in NIH/3T3 whole cell lysate
All lanes:
Immunoprecipitation - Anti-NEK7 antibody [EPR4900] (ab133514)
Predicted band size: 35 kDa
false
- WB
Lab
Western blot - Anti-NEK7 antibody [EPR4900] (AB133514)
Lane 1 : Wild-type HAP1 cell lysate (40 μg)
Lane 2 : NEK7 knockout HAP1 cell lysate (40 μg)
Lane 3 : A549 cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133514 observed at 35 kDa. Red - loading control, ab18058, observed at 124 kDa.
ab133514 was shown to specifically react with NEK7 when NEK7 knockout samples were used. Wild-type and NEK7 knockout samples were subjected to SDS-PAGE. ab133514 and ab18058 (loading control to Vinculin) were diluted at 1/10000 and 1/10,000 dilution respectively and incubated overnight at 4C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NEK7 antibody [EPR4900] (ab133514)
Predicted band size: 35 kDa
false
- WB
Unknown
Western blot - Anti-NEK7 antibody [EPR4900] (AB133514)
All lanes:
Western blot - Anti-NEK7 antibody [EPR4900] (ab133514) at 1/10000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Lane 2:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 35 kDa
false
- WB
Unknown
Western blot - Anti-NEK7 antibody [EPR4900] (AB133514)
All lanes:
Western blot - Anti-NEK7 antibody [EPR4900] (ab133514) at 1/10000 dilution
Lane 1:
Jurkat cell lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
C6 cell lysate at 10 µg
Lane 4:
RAW264.7 cell lysate at 10 µg
Lane 5:
PC12 cell lysate at 10 µg
Lane 6:
NIH/3T3 cell lysate at 10 µg
Secondary
All lanes:
Goat-anti-rabbit HRP at 1/2000 dilution
Predicted band size: 35 kDa
Observed band size: 32 kDa
true
- WB
CiteAb
Western blot - Anti-NEK7 antibody [EPR4900] (AB133514)
Western Blotting using Anti-NEK7 antibody [EPR4900], ab133514. Publication image from Li, X. et al., 2017, Nat Commun, 28656979. Legend direct from paper.
Loss of MARK4 affects IL-1β production under NLRP3 inflammasome activation.(a) Mark4 expression under unprimed and LPS primed conditions in mouse bone marrow-derived macrophages (BMDM). Cytoplasm proximity ligation assay (PLA) signal per cell cytoplasm is used for quantification. Mean±s.e.m. for all the cells taken from 5 to 8 different views at x 40 magnification for each group. Experiments have been repeated three times. Scale bar, 10 µm. (b) siRNA of MARK4, NLRP3 or ASC caused reduction of ATP induced IL-1β production in THP-1 cells. (c) shRNA of MARK4 caused reduction of IL-1β induced by NLRP3 stimuli, including monosodium urate (MSU) and cholesterol crystals (CC) in THP-1 cells. Mock represents macrophages without further stimulation. (d) BMDM derived from Mark4 KO mice exhibited selectivity towards NLRP3 activating stimuli. Mean±s.e.m., three to four independent experiments combined (b–d), comparisons of the two different groups were analysed by unpaired t test. NS was considered as not statistically significant. *P<0.05, **P<0.01 and ***P<0.001 were considered as statistically significant (a–d). (e) Representative western blots of caspase-1 (Casp1) and IL-1β in the supernatant (Sup.) in Mark4+/+ and Mark4−/− macrophages activated with indicated stimuli. Cell lysates were used as controls to indicate equal amount of cells for analysis.
false
Related conjugates and formulations (1)
-
Anti-NEK7 antibody [EPR4900] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-NEK7 antibody [EPR4900] (ab133514) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human, Mouse, Rat samples.
What is the molecular weight of NEK7?
Anti-NEK7 [EPR4900] (ab133514) specifically detects a band for NEK7 (UniProt: Q8TDX7) at a molecular weight of 35kDa.
Trusted by the scientific community
Anti-NEK7 [EPR4900] (ab133514) was first used in a scientific publication in 2012 and has been cited over 60 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-NEK7 antibody [EPR4900] (ab133514) has been confirmed by Western blot testing in NEK7 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR4900] also available for your convenience: ab133514, Carrier free - ab240065
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cell cycle progression heavily depends on NEK7's function. NEK7 interacts with NEDD1 in the microtubule-organizing center contributing to centrosome maturation and separation. This interaction makes NEK7 vital in the recruitment of γ-tubulin ring complex which is necessary for nucleating microtubules. NEK7 operates independently from the other NEK family members but shares involvement in centrosome-related activities.
Pathways
NEK7 is influential in the regulation of the mitotic spindle assembly pathway and the interleukin-1 (IL-1) signaling pathway. It is closely related to proteins like NEK6 and NEK9 which also play roles in mitotic progression and cytokinesis. NEK7's involvement in these pathways indicates its integrative function in ensuring normal cell division and response to inflammatory signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (85)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:154 PubMed40280946
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadq4266 PubMed40053593
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed39998486
2025
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38:e70248 PubMed39673686
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular brain 17:81 PubMed39563448
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1423053 PubMed39508038
2024
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 5:103417 PubMed39460941
2024
Applications
Unspecified application
Species
Unspecified reactive species
eLife 12: PubMed38953285
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 213:481-493 PubMed38949555
2024
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2308786 PubMed38696610
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com